Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;32(5):442-58.
doi: 10.1002/dmrr.2827.

Standards of Care for Type 2 Diabetes in China

Affiliations
Free PMC article

Standards of Care for Type 2 Diabetes in China

Jianping Weng et al. Diabetes Metab Res Rev. .
Free PMC article

Figures

Figure 1
Figure 1
The treatment algorithm for high blood glucose in T2DM. The blue paths are the recommended primary drug treatment paths based on comprehensive considerations, including clinical evidence of the drug's health economics, efficacy and safety and China's national conditions. These paths are similar to the drug treatment pathways recommended by most international diabetes guidelines. The orange paths are alternative paths for the corresponding blue paths. HbA1c, glycated haemoglobin; DPP‐4, dipeptidyl peptidase IV; TZD, thiazolidinedione; GLP‐1, glucagon‐like peptide‐1
Figure 2
Figure 2
Insulin treatment paths for T2DM. HbA1c, glycated haemoglobin; FPG, fasting plasma glucose; CSII, continuous subcutaneous insulin infusion
Figure 3
Figure 3
The clinical decision‐making paths for screening and the standard lipid‐lowering, antihypertensive and antiplatelet treatments for patients with T2DM. ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor antagonist; LDL‐C, low‐density lipoprotein cholesterol

Similar articles

See all similar articles

Cited by 64 articles

See all "Cited by" articles

References

    1. National Diabetes Study Group . A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China. Zhonghua Nei Ke Za Zhi 1981; 20(11): 678–683. - PubMed
    1. Pan XR, Yang WY, Li GW, et al., Prevalence of diabetes and its risk factors in China, 1994 . National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20(11): 1664–1669. - PubMed
    1. Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26(7): 478–484. - PubMed
    1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090–1101. - PubMed
    1. Chinese Diabetes Society . China guideline for type 2 diabetes (2010). Chin J Diabetes 2012; 20(1): S1–S36.
Feedback